000			04146nam a22004695i 4500
999			_c120624 _d120624
001			120624
003			ES-MaUEC
005			20230102114052.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			200612s2020 si a o |||| 0|eng d
020			_a9789811538957
024	7		_a10.1007/978-981-15-3895-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM301.3.G45 _b2020 EB
245	0	0	_aPharmacogenomics in Precision Medicine : _bFrom a Perspective of Ethnic Differences _cedited by Weimin Cai, Zhaoqian Liu, Liyan Miao, Xiaoqiang Xiang
250			_aFirst edition
264		1	_aSingapore _bSpringer International Publishing _c2020
300			_a1 recurso en línea (VIII, 289 páginas) _b33 ilustraciones, 26 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aChapter 1. Introduction and Principles of Pharmacogenomics and Precision medicine -- Chapter 2. Pharmacogenomics in Cardiovascular Diseases -- Chapter 3. Pharmacogenomics of Antitumor Chemotherapeutic Agents -- Chapter 4. Pharmacogenomics of Antitumor Targeted Agent and Immunotherapy -- Chapter 5. Pharmacogenomics of Immunosuppressant -- Chapter 6. Pharmacogenomics of Psychiatric drugs -- Chapter 7. Pharmacogenomics of Anti-Infective Agents -- Chapter 8. Pharmacogenomics of Antithrombotic drugs -- Chapter 9. Pharmacogenomics in Therapeutic Drug Monitoring -- Chapter 10. Pharmacomicrobiomics -- Chapter 11. Genotyping technology in Pharmacogenomics -- Chapter 12. The Ethical, Legal and Regulatory Issues Associated with Pharmacogenomics -- Chapter 13. Cost-effectiveness of pharmacogenetic-guided treatment -- Chapter 14. Application of pharmacogenomics in drug discovery and development -- Chapter 15. Barriers and Solutions in Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine.
520	3		_aThis book provides an introduction to the principles of pharmacogenomics and precision medicine, followed by the pharmacogenomics aspects of major therapeutic areas such as cardiovascular disease, cancer, organ transplantation, psychiatry, infection, antithrombotic drugs. It also includes genotyping technology and therapeutic drug monitoring in Pharmacogenomics; ethical, Legal and Regulatory Issues; cost-effectiveness of pharmacogenetics-guided treatment; application of pharmacogenomics in drug discovery and development and clinical Implementation of Pharmacogenomics for Personalized Precision Medicine. The contributors of Pharmacogenomics in Precision Medicine come from a team of experts, including professors from academic institutions and practitioner from hospital. It will give an in-depth overview of the current state of pharmacogenomics in drug therapy for all health care professionals and graduate students in the era of precision medicine.
988			_aSpringer_Biomedlife_23062020
650		7	_aFarmacogenómica _2embne _9165192
650		7	_aGenética humana _2embne _9140562
650		7	_aMedicina experimental _2embne _9146841
700	1		_aCai, Weimin _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt _0http://id.loc.gov/authorities/names/nr2002014747 _1http://viaf.org/viaf/68865442
700	1		_aLiu, Zhaoqian _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aMiao, Liyan _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aXiang, Xiaoqiang _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729
776	0	8	_iPrinted edition: _z9789811538940
776	0	8	_iPrinted edition: _z9789811538964
776	0	8	_iPrinted edition: _z9789811538971
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-15-3895-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b07/2020 _dz _eo _zSI